The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0

被引:0
|
作者
Jonathan Kuten
Snir Dekalo
Ishai Mintz
Ofer Yossepowitch
Roy Mano
Einat Even-Sapir
机构
[1] Tel-Aviv Sourasky Medical Center,Departments of Nuclear Medicine
[2] Tel-Aviv Sourasky Medical Center,Departments of Urology
[3] Tel-Aviv University,Sackler School of Medicine
来源
关键词
68 Ga-PSMA; PET/CT; Prostate cancer; Equivocal; Bone metastases;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 7 条
  • [1] The significance of equivocal bone findings in staging PSMA imaging in the preoperative setting: validation of the PSMA-RADS version 1.0
    Kuten, Jonathan
    Dekalo, Snir
    Mintz, Ishai
    Yossepowitch, Ofer
    Mano, Roy
    Even-Sapir, Einat
    EJNMMI RESEARCH, 2021, 11 (01)
  • [2] PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA-targeted PET Imaging Studies
    Rowe, Steven P.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    EUROPEAN UROLOGY, 2018, 73 (04) : 485 - 487
  • [3] Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0
    Rowe, Steven P.
    Pienta, Kenneth J.
    Pomper, Martin G.
    Gorin, Michael A.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (03) : 479 - 485
  • [4] Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging
    Werner, Rudolf A.
    Bundschuh, Ralph A.
    Bundschuh, Lena
    Javadi, Mehrbod S.
    Leal, Jeffrey P.
    Higuchi, Takahiro
    Pienta, Kenneth J.
    Buck, Andreas K.
    Pomper, Martin G.
    Gorin, Michael A.
    Lapa, Constantin
    Rowe, Steven P.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (12) : 1857 - 1864
  • [5] Bone Uptake in Prostate Cancer Patients Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence
    Letang, Anouk
    Crombe, Amandine
    Rousseau, Caroline
    Sargos, Paul
    Merlin, Charles
    Cantarel, Coralie
    Cazeau, Anne-Laure
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (08) : E529 - E539
  • [6] Analysis of pathological findings in 18F-DCFPyL PSMA PET in recurrence of prostate cancer according to PSMA-RADS classification and E-PSMA overexpression score. Confirmation of results by pathological anatomy, biochemical response or imaging.
    Hervas-Sanz, B.
    Robles-Barba, J. J.
    Martin-Marcuartu, J. J.
    Bondia-Bescos, S.
    Pudis, M.
    Romero-Herrera, J. E.
    Reynes-Llompart, G.
    Ferrer-Gonzalez, F.
    Suarez-Novo, J. F.
    Cortes-Romera, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S529 - S530
  • [7] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in intermediate and high risk prostate cancer primary staging: a single center retrospective analysis of semiquantitative PET/CT parameters, bio-distribution and clinical significance of potential equivocal non-specific findings (NS-F)
    Paone, G.
    Cuzzocrea, M.
    Treglia, G.
    Ruberto-Macchi, T.
    Raditckova-Sarnelli, M.
    Ceriani, L.
    Giovanella, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S485 - S485